Obesity
From the Journals
‘Clinical paradox’? Bariatric surgery may protect from GI cancers
The study marks “an important step toward improving the understanding of potential lifetime risks of bariatric surgery and overall major health...
From the AGA Journals
Earlier colorectal cancer screening appears cost-effective in overweight, obese patients
Starting colonoscopy at age 45 seems to be cost-effective for both men and women.
Perspectives
Weight loss management ... a new frontier?
How do we choose from this growing armamentarium of minimally invasive procedures and weight loss medicines? What combination is best? And what...
From the Journals
FMT doesn’t appear to affect weight loss after bariatric surgery
There is much interest in the gut microbiota as a potential target for the treatment of obesity. FMT from a lean donor has shown promise in...
From the Journals
Rates of health care use after bariatric surgery in teens
Researchers found significantly lower rates of emergency department (ED) use and hospitalization 5 years after sleeve gastrectomy compared with...
Conference Coverage
Risk factors ID’d for acute pancreatitis from weight-loss drugs
“With obesity being such a global issue, there are many patients on these GLP-1 agonists.”
Short Clinical Reviews
Lean and clean: Minimally invasive endoscopic and pharmacologic approaches to obesity
Endoscopic bariatric therapy and antiobesity medications have blossomed because of the need for less-invasive options to stimulate weight loss.
From the Journals
Are artificial sweeteners really harmless?
New research suggests that sugar substitutes are not metabolically inert but can alter the gut microbiome in a way that can influence blood...
From the Journals
Ultrasound on par with CT for evaluating sarcopenia in patients with cirrhosis
Ultrasound-based assessment presents a more affordable point-of-care strategy that limits radiation exposure, which enables sequential monitoring...
From the Journals
MERIT: Endoscopic sleeve gastroplasty shows ‘very impressive’ outcomes in randomized clinical trial
ESG is a minimally invasive, reversible, organ-sparing bariatric procedure that might be able to fill care gaps left by traditional approaches.